These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 2243140)

  • 1. Arginine-glycine-aspartic acid- and fibrinogen gamma-chain carboxyterminal peptides inhibit platelet adherence to arterial subendothelium at high wall shear rates. An effect dissociable from interference with adhesive protein binding.
    Lawrence JB; Kramer WS; McKeown LP; Williams SB; Gralnick HR
    J Clin Invest; 1990 Nov; 86(5):1715-22. PubMed ID: 2243140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate.
    Weiss HJ; Hawiger J; Ruggeri ZM; Turitto VT; Thiagarajan P; Hoffmann T
    J Clin Invest; 1989 Jan; 83(1):288-97. PubMed ID: 2910912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that the arg1744 gly1745 asp1746 sequence in the GPIIb-IIIa-binding domain of von Willebrand factor is involved in platelet adhesion and thrombus formation on subendothelium.
    Weiss HJ; Hoffmann T; Yoshioka A; Ruggeri ZM
    J Lab Clin Med; 1993 Sep; 122(3):324-32. PubMed ID: 8409708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins.
    Lu X; Williams JA; Deadman JJ; Salmon GP; Kakkar VV; Wilkinson JM; Baruch D; Authi KS; Rahman S
    Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):929-36. PubMed ID: 7529494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic RGDS-containing peptides of von Willebrand factor inhibit platelet adhesion to collagen.
    Fressinaud E; Girma JP; Sadler JE; Baumgartner HR; Meyer D
    Thromb Haemost; 1990 Dec; 64(4):589-93. PubMed ID: 2084945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. von Willebrand factor contained in a high purity FVIII concentrate (Fanhdi) binds to platelet glycoproteins and supports platelet adhesion to subendothelium under flow conditions.
    Rivera J; Escolar G; Casamiquela R; Bravo MI; Jorquera JI; Castillo R; Ordinas A; Vicente V
    Haematologica; 1999 Jan; 84(1):5-11. PubMed ID: 10091386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets.
    Plow EF; Pierschbacher MD; Ruoslahti E; Marguerie GA; Ginsberg MH
    Proc Natl Acad Sci U S A; 1985 Dec; 82(23):8057-61. PubMed ID: 3877935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of platelet adhesion to fibrin(ogen) in flowing whole blood by Arg-Gly-Asp and fibrinogen gamma-chain carboxy terminal peptides.
    Hantgan RR; Endenburg SC; Cavero I; Marguerie G; Uzan A; Sixma JJ; de Groot PG
    Thromb Haemost; 1992 Dec; 68(6):694-700. PubMed ID: 1287884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the role of platelet membrane glycoproteins in the platelet-vessel wall interaction.
    Nurden AT; Nurden P
    Baillieres Clin Haematol; 1993 Sep; 6(3):653-90. PubMed ID: 8025347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycoprotein IIb-IIIa and RGD(S) are not important for fibronectin-dependent platelet adhesion under flow conditions.
    Nievelstein PF; Sixma JJ
    Blood; 1988 Jul; 72(1):82-8. PubMed ID: 2968824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies to the glycoprotein IIb-IIIa epitopes involved in adhesive protein binding: effects on platelet spreading and ultrastructure on human arterial subendothelium.
    Lawrence JB; Gralnick HR
    J Lab Clin Med; 1987 Apr; 109(4):495-503. PubMed ID: 2434592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of thrombin-activated platelets with extracellular matrices (fibronectin and vitronectin): comparison of the activity of Arg-Gly-Asp-containing venom peptides and monoclonal antibodies against glycoprotein IIb/IIIa complex.
    Sheu JB; Ko WC; Hung WC; Peng HC; Huang TF
    J Pharm Pharmacol; 1997 Jan; 49(1):78-84. PubMed ID: 9120775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and characterization of peptide-specific antibodies that inhibit von Willebrand factor binding to glycoprotein IIb-IIIa without interacting with other adhesive molecules. Selectivity is conferred by Pro1743 and other amino acid residues adjacent to the sequence Arg1744-Gly1745-Asp1746.
    Berliner S; Niiya K; Roberts JR; Houghten RA; Ruggeri ZM
    J Biol Chem; 1988 Jun; 263(16):7500-5. PubMed ID: 2453507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of platelet-von Willebrand factor binding to platelets by adhesion site peptides.
    Parker RI; Gralnick HR
    Blood; 1989 Sep; 74(4):1226-30. PubMed ID: 2548639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of platelet membrane glycoproteins Ib and IIb-IIIa in platelet adherence to human artery subendothelium.
    Sakariassen KS; Nievelstein PF; Coller BS; Sixma JJ
    Br J Haematol; 1986 Aug; 63(4):681-91. PubMed ID: 2942171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asialo von Willebrand factor enhances platelet adhesion to vessel subendothelium.
    Bastida E; Monteagudo J; Ordinas A; De Marco L; Castillo R
    Thromb Haemost; 1988 Aug; 60(1):30-4. PubMed ID: 3263711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c7E3 Fab inhibits low shear flow modulated platelet adhesion to endothelium and surface-absorbed fibrinogen by blocking platelet GP IIb/IIIa as well as endothelial vitronectin receptor--results from patients with acute myocardial infarction and healthy controls.
    Reininger AJ; Agneskirchner J; Bode PA; Spannagl M; Wurzinger LJ
    Thromb Haemost; 2000 Feb; 83(2):217-23. PubMed ID: 10739376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-idiotypic antibodies against an antibody to the platelet glycoprotein (GP) IIb-IIIa complex mimic GP IIb-IIIa by recognizing fibrinogen.
    Abrams CS; Ruggeri ZM; Taub R; Hoxie JA; Nagaswami C; Weisel JW; Shattil SJ
    J Biol Chem; 1992 Feb; 267(4):2775-85. PubMed ID: 1370832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of von Willebrand factor binding to platelets by two recognition site peptides: the pentadecapeptide of the carboxy terminus of the fibrinogen gamma chain and the tetrapeptide arg-gly-asp-ser.
    Williams S; Gralnick H
    Thromb Res; 1987 May; 46(3):457-71. PubMed ID: 3037722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and characterization of specific antibodies directed to the binding domain of adhesive molecules.
    Berliner SA; Roberts JR; Thorn ML; Ruggeri ZM
    Pept Res; 1988; 1(2):60-4. PubMed ID: 2485226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.